Center for Continuing Education
About The Cleveland Clinic Center for Continuing Education | Call or Email Us | About The Cleveland Clinic
Live Cleveland Clinic CME Courses |  Regularly Scheduled Series (RSS) Registration | Regulary Scheduled Series (RSS) Schedule (pdf)
Disease Management Project Clinical Decisions Cases |  Hepatitis C Management |  Managing Problem Patients with Anti-TNF Inhibitors |  More
Medicine Today Series |  B Cell Series |  Emerging Therapies in Heart Disease Webcast Series |  More
Disease Management Project |  CCJM 1-Minute Consult |  Pharmacotherapy Update Newsletter |  Algorithms for the MICU |  More
Cleveland Clinic Foundation CME Home Contact Us Live CME Courses Online CME Topics Webcasts Online Medical Publications my CME Search Sitemap e-mail Newsletter

How to Obtain AMA PRA Category 1 Credit(s)™

  1. Watch the CME Webcast.
  2. Take the CME posttest.
  3. Login to your account.
  4. Complete the registration / evaluation form.
  5. Print your personalized CME certificate.

 


 

   
 
Biologic Therapeutic Classes and Agents:
Shared Mechanisms of Action Across Disease States
 
Release Date: January 11, 2008 Expiration Date: January 11, 2009
 

Technical Requirements
(will appear in new window)

 

Accreditation

2.0 AMA PRA Category 1 Credit(s)™.

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity may be submitted for American Osteopathic Association Continuing Medical Education credit in Category 2.

Target Audience

This activity will be directed to rheumatologists, gastroenterologists, dermatologists, pulmonologists, nurse practitioners, physician assistants, and other health care professionals interested in or using biologic therapeutics in autoimmune and inflammatory disorders.

Description

This activity was presented at the Cleveland Clinic Richard J. Fasenmyer Center of Clinical Immunology Biologic Therapies for Autoimmune and Inflammatory Disease States Summit. The reviewed advances in biologic therapies for autoimmune diseases.

Objectives

At the conclusion of this activity, the participant will be able to:

  1. Discuss the current status of biologic therapies for osteoporosis
  2. Review the potential targets for biologic agents in the pathways leading to osteoclast, osteoblast and osteocyte activation
  3. Explain the rationale and possible mechanisms of B cell targeting strategies
  4. Describe the results of clinical trials using B cell targeted therapy
  5. List the benefits TNFa inhibitors have in RA and other arthritides

Activity Director

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman
Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology

Author

Ferdinand Breedveld, MD
Chad Deal, MD
E. William St. Clair, MD
Vibeke Strand, MD

Faculty Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:

Leonard Calabrese, DO
  Consulting, Teaching and Speaking Genentech

Teaching and Speaking Abbott; Amgen; Wyeth
 
Ferdinand Breeveld, MD
  Consulting, Teaching and Speaking Abbott; Centocor; Merck; Pfizer; Roche; Schering-Plough; Wyeth
 
Chad Deal, MD



Consulting and Research Amgen
  Consulting, Teaching, and Speaking, Membership on Advisory Committee or
Review Panels
Eli Lilly
 
E. William St. Clair, MD
Consulting

Bristol Myers Squibb;
Human Genome Sciences; Medimmune; Novartis





Consulting and Research Genentech



Board Membership Synovex



Research Amgen
 
Vibeke Strand, MD





Consulting, Teaching and Speaking, Membership on Advisory Committee or
Review Panel
Abbott Immunology; Amgen; Centocor




Membership on Advisory Committee or
Review Panel
Biogen IDEC




Consulting and Membership on Advisory Committee or Review Panel BMS




Teaching and Membership on Advisory Committee or Review Panel Centocor; Pfizer



Consulting Genentech; UCB
  Consulting and Membership on Advisory Committee or Review Panel Roche
Estimated Time of Completion 2 hours

The Cleveland Clinic Foundation Center for Continuing Education acknowledges an educational grant for support of this activity from:

PLATINUM LEVEL

Abbott Amgen Bristol-Myers Squibb
Genentech and Biogen Idec.

Gold Level

This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education and UNITECH Communications®.

Contact Information | Privacy Policy | Disclaimer

Copyright © 2008 The Cleveland Clinic Foundation. All Rights Reserved.